Negative assumptions about people with Down syndrome can become self-fulfilling prophecies. Try positive assumptions and maybe we can create more opportunities at school, in the workforce, in sports, and in social life.  #AssumeICan   #EndTheStereotypes #WDSD24

.@AANMember has updated its position statement on #prescription drug prices, establishing its stance on different methods to address the cost of prescription drugs under consideration by lawmakers: bit.ly/4c5jA7e

#NeuroTwitter #medication Jonathan Santoro, MD

The AAN asks Congress to maintain robust funding for NINDS in FY 24 and FY 25 to sustain both programs' momentum. bit.ly/49CpgUR

#NOH24 #NeuroTwitter #Neurology

Another breakthrough at Children's Hospital LA! Our fellow Saba Jafarpour, MD has published a report of neuropathologic findings in a child with #AicardiGoutieres Syndrome treated with #immunotherapy . Informing on the potential of JAK inhibitors in the future.

pubmed.ncbi.nlm.nih.gov/38381212/

New year, new opportunities! Looking for a postdoc to join our group USC USC CGE, to work on exciting projects related to understanding the origins of childhood leukemia and disparities in leukemia risk.

Info here: usccareers.usc.edu/job/los-angele…
Population and Public Health Sciences at USC #epitwitter 🧬🩸🌞

Excited to share our recent work on #neuroimaging abnormalities in individuals with #DownSyndrome Regression Disorder at Children's Hospital LA. Neuroimaging abnormalities predict immunotherapy responsiveness in this unique patient population! Linda Crnic Institute for Down Syndrome

onlinelibrary.wiley.com/doi/epdf/10.10…

The AAN has updated its position statement on prescription drug prices. bit.ly/3uqHglJ

@jerrymoran Representative Davids, Senator Marshall and Senator Moran please urge Congressional leadership to put patients first and include the #SafeStepAct in upcoming PBM reform legislation #AANadvocacy

High drug costs are disproportionately affecting individuals with #neurological conditions. It was a pleasure working with the American Academy of Neurology on a revised position statement on this important, and complex, issue. Children's Hospital LA Child Neurology Society

pubmed.ncbi.nlm.nih.gov/38335469/

For years, doctors have complained about the demands of seeking #PriorAuthorization for therapies. Neurologists and health care leaders share ideas for revamping the process: bit.ly/48JBvhv
#NeuroTwitter Jonathan Santoro, MD Kavita Nair David A Evans Ryan Clarkson Justin T. Jordan, MD, MPH, FAAN

Very interesting study out of Children's Hospital LA on the safety and tolerability of #IVIg in the treatment of #DownSyndrome Regression Disorder. IV therapies in this population may be easier to use than previously thought! National Down Syndrome Society Global Down Syndrome Foundation

pubmed.ncbi.nlm.nih.gov/38169137/

Tulane students were featured on CBS News for their work building wheelchair prototypes for toddlers, a project that exemplifies our commitment to service and life-changing impact.

Check out their story ⤵️

Great work by our visiting medical student Justin Abe from the John A. Burns School of Medicine on hormonal changes and #Pediatric #MultipleSclerosis ! A fantastic collaborations for our students and trainees at Children's Hospital LA.

frontiersin.org/articles/10.33…

Thanks to a generous $10 million gift from The Chuck Lorre Family Foundation—Children's Hospital Los Angeles has established the Chuck Lorre Research Scholars Program, which welcomed its inaugural class in the summer of 2023. chla.org/blog/hospital-…

Honored to be giving this talk on an important topic!

Diagnostic Yield of Epilepsy-Genes Sequencing and Chromosomal Microarray in Pediatric Epilepsy dlvr.it/Sz2NNY

This Emerging Issues in Neurology article provides practical guidance for a wide audience of neurology clinicians on adaptations and decision-making around emerging antiamyloid monoclonal antibodies: bit.ly/3QQkMTp

#NeuroTwitter #Alzheimer

🤯🤯🤯talk by Jonathan Santoro, MD on Down syndrome regressive disorder
Including:
-immunotherapy works!
- 50% can wean off immunotherapy after 1 year
-biomarkers can help predict immunotherapy response and relapse
- now a new clinical trial

#CNSAM Child Neurology Society

Very interesting article on the impact of radiographic findings in children with #afm (Acute Flaccid Myelitis). Biomarkers like these are critical in rare and ultra rare diseases! Great work Dr. Caceres and Team! #NeuroTwitter

sciencedirect.com/science/articl…

‘The MOG Project, Pediatric Neurologist Secure CDC Approval to Adopt ICD-10 Code for Rare Disease MOGAD’- Congrats to Jonathan Santoro, MD, Julia & everyone else who made this happen. In 2024, #MOGAD will officially be its on seperate disease with its own code!

prweb.com/releases/the-m…